Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02078401

Enrollment

200

Registered

2014-03-05

Start date

2014-04-30

Completion date

Unknown

Last updated

2014-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatosis Type 1

Keywords

Optic pathway glioma, Ophthalmological screening

Brief summary

The goal of this project is to get more insight into the (neuro)ophthalmological characteristics of children with neurofibromatosis type 1. This way investigators would like to update the current guidelines for follow up and treatment of optic pathway gliomas. Clinical findings will be compared with the results of Optical coherence tomography (OCT) and MRI (magnetic resonance imaging).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* neurofibromatosis type 1

Exclusion criteria

* no neurofibromatosis type 1

Design outcomes

Primary

Measure	Time frame
Visual acuity	childhood (0 to 18y)
Presence of optic pathway glioma	childhood (0 to18y)

Countries

Belgium

Contacts

Primary ContactCatherine Cassiman, MD

catherine.cassiman@uzleuven.be00321632660

Outcome results